BILL BILL - Catena di Opzioni | ADVFN

Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Registrati

Home
Investire
Azioni
U.S.A.
NYSE
BILL Holdings Inc (BILL)
BILL Holdings Inc (BILL) Opzioni

BILL Holdings Inc (BILL)

48,57

-1,73

(-3,44%)

Chiuso 26 Marzo 9:00PM

Ritardato di 15 minuti

48,20

-0,37

( -0,76% )

Pre Mercato: 12:00PM

Ritardato di 15 minuti

BILL Flusso Di Opzioni

Call

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
43,00	5,20	6,50	4,20	5,85	0,00	0,00 %	0	2	-
43,50	4,60	6,20	0,00	5,40	0,00	0,00 %	0	0	-
44,00	4,40	5,00	3,00	4,70	0,00	0,00 %	0	40	-
44,50	3,60	4,50	2,77	4,05	0,00	0,00 %	0	7	-
45,00	3,50	3,90	3,50	3,70	-2,08	-37,28 %	1	45	26/3/2025
45,50	2,95	3,60	2,75	3,275	0,00	0,00 %	0	8	-
46,00	1,95	2,95	2,85	2,45	0,00	0,00 %	0	4	-
46,50	1,30	2,40	4,06	1,85	0,00	0,00 %	0	5	-
47,00	1,15	1,95	3,62	1,55	0,00	0,00 %	0	13	-
47,50	1,40	1,55	1,45	1,475	-1,55	-51,67 %	5	43	26/3/2025
48,00	0,70	1,20	3,31	0,95	0,00	0,00 %	0	16	-
48,50	0,30	0,90	1,25	0,60	-1,37	-52,29 %	4	74	26/3/2025
49,00	0,55	0,65	2,12	0,60	0,00	0,00 %	0	40	-
49,50	0,35	0,50	0,40	0,425	-1,10	-73,33 %	24	45	26/3/2025
50,00	0,20	0,35	0,28	0,275	-0,57	-67,06 %	8	91	26/3/2025
51,00	0,10	0,20	0,16	0,15	-0,39	-70,91 %	10	104	26/3/2025
52,00	0,05	0,15	0,05	0,10	-0,25	-83,33 %	34	106	26/3/2025
53,00	0,10	0,15	0,13	0,125	0,03	30,00 %	3	1.009	26/3/2025
54,00	0,15	0,10	0,07	0,125	-0,08	-53,33 %	1	105	26/3/2025
55,00	0,05	0,75	0,05	0,40	0,00	0,00 %	0	39	-

Strumenti di livello professionale, per investitori individuali

Put

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
43,00	0,04	0,05	0,04	0,045	0,00	0,00 %	0	40	-
43,50	0,44	0,75	0,44	0,595	0,00	0,00 %	0	124	-
44,00	0,05	0,05	0,05	0,05	0,00	0,00 %	0	22	-
44,50	0,22	0,10	0,22	0,16	0,00	0,00 %	0	17	-
45,00	0,05	0,10	0,03	0,075	-0,02	-40,00 %	20	167	26/3/2025
45,50	1,06	0,15	1,06	0,605	0,00	0,00 %	0	5	-
46,00	0,05	0,15	1,55	0,10	0,00	0,00 %	0	16	-
46,50	0,10	0,25	0,10	0,175	0,00	0,00 %	0	645	-
47,00	0,20	0,30	0,25	0,25	-0,60	-70,59 %	12	73	26/3/2025
47,50	0,30	0,40	1,40	0,35	0,00	0,00 %	0	52	-
48,00	0,45	0,60	0,25	0,525	0,05	25,00 %	1	72	26/3/2025
48,50	0,65	0,80	0,45	0,725	0,00	0,00 %	0	14	-
49,00	0,90	1,05	0,98	0,975	-0,87	-47,03 %	2	25	26/3/2025
49,50	1,20	2,30	1,30	1,75	0,60	85,71 %	4	6	26/3/2025
50,00	1,55	1,80	1,66	1,675	1,16	232,00 %	7	72	26/3/2025
51,00	2,35	2,65	1,55	2,50	0,24	18,32 %	2	14	26/3/2025
52,00	3,10	3,60	2,30	3,35	1,05	84,00 %	1	12	26/3/2025
53,00	3,30	5,00	5,50	4,15	0,00	0,00 %	0	2	-
54,00	4,90	5,80	9,00	5,35	0,00	0,00 %	0	10	-
55,00	6,20	8,10	4,00	7,15	0,00	0,00 %	0	34	-

Più Attivi
% Guadagnanti
% Perdenti

Simbolo	Prezzo	Vol.
LYTLytus Technologies Holdings PTV Ltd	US$ 0,1326 (112,84%)	153,91M
GTECGreenland Technologies Holding Corporation	US$ 2,42 (84,73%)	22,53M
FKWLFranklin Wireless Corporation	US$ 8,99 (55,27%)	130
NSTSNSTS Bancorp Inc	US$ 18,15 (54,07%)	4
AEYEAudioEye Inc	US$ 17,95 (52,51%)	113
RVYLRYVYL Inc	US$ 0,45 (-57,94%)	1
PPIHPerma Pipe International Holdings Inc	US$ 7,01 (-48,79%)	2
ESSAESSA Bancorp Inc	US$ 10,01 (-47,20%)	3
BOTJBank of the James Financial Group Inc	US$ 8,01 (-44,91%)	10
TBLDThomburg Income Builder Opportunities Trust	US$ 10,01 (-43,67%)	1
LYTLytus Technologies Holdings PTV Ltd	US$ 0,1326 (112,84%)	153,91M
OCEAOcean Biomedical Inc	US$ 0,107 (27,84%)	73,58M
GTIGraphjet Technology	US$ 0,1217 (13,31%)	64,81M
GTECGreenland Technologies Holding Corporation	US$ 2,42 (84,73%)	22,53M
DMNDamon Inc	US$ 0,043 (10,54%)	22,16M

stocktowatch

stocktowatch 3 minuti fa

$ALLR Allarity Therapeutics (ALLR): A Biotech Turnaround With FDA Fast-Track Potential
https://docs.google.com/document/d/18xKdntXBscs8Qpbx3DUZJCPhEPuLPOly3G1UonXYNeo/edit?tab=t.0#heading=h.ntykmz6baety

Mountdallas

Mountdallas 4 minuti fa

Bud you just wrote a 1000 word essay to 4 people congrats

work-n-hard

work-n-hard 5 minuti fa

ALLR: Doubled up @ 1.08, so essentially got my 1.10's from yesterday's 1.12's. 😜

band aid

band aid 6 minuti fa

What a sham this thing is Period.

gorbec1

gorbec1 6 minuti fa

I wish you the best anyone that held for a long time a lot of shares deserve it

rikkie

rikkie 6 minuti fa

This is a significant leap forward from modulators in common use today, most of which are based on materials such as lithium niobate (LiNbO3), indium gallium arsenide (InGaAs), and, more recently, silicon. Modulators using these materials typically have a frequency response that drops off as frequen

chereb19

chereb19 6 minuti fa

Any yet but the Mayo Clinic still stick around

Their unpaid member of staff sits on the Vivos medical advisory board

Got to Occam, Mayo knows more than you and you know shit.

Tick tock

https://investorshub.advfn.com/uimage/uploads/2025/3/23

arachnodude

arachnodude 7 minuti fa

Oh, believe me — I could never forget. My thousands of deleted posts serve as a constant reminder.

It’s wild how the smacktalk about the company and its personnel not only gets a free pass but practically seems encouraged. As long as the insults are aimed in the “right” direction, it’

sirant

sirant 7 minuti fa

I believe that and more is coming. JMHO
GO $MCIC

$7.00 or Nothing

$7.00 or Nothing 7 minuti fa

But it’s ok to talk to Purdue? lol haha the clown king

Polymer Paul

Polymer Paul 10 minuti fa

Another day .. another jeunke Nvidia post !!!! Wow .. you really are like a crack head who needs hos daily Nvidia hit????? Any newbies on here ... These are facts .. jeunke has posted thousands of messages tagging Nvidia in them trying to pump this scam. .. however .. there's not one tiny little bit

buylow2

buylow2 10 minuti fa

Hey loc, good not enough time to respond. So busy the last 10 years doing nothing.

SkeBallLarry

SkeBallLarry 10 minuti fa

" Wow ... thank you for that, K2 " .. !!

SC8

SC8 10 minuti fa

What "Lying"?

MK said in July (after withdrawing his IDE application) that he was confident the application would resubmitted within 45 days, and here in March 2025 (after dozens of further meetings with FDA) he’s now saying 2nd quarter this year. It's clear as day he fubared the a

sirant

sirant 11 minuti fa

GOOD MORNING EVERYONE
GO $MCIC

gt1217

gt1217 11 minuti fa

Always an angle, everything that people post videos on are trying to get people to like follow etc. Who is in his pocket? What's his MO? And who really cares what someone says. It will do what it does. Public in general over extend theirs elves in crypto to get rich quick. Those that hold over time

Copilotdog

Copilotdog 12 minuti fa

Starting a beverage shouldn't take a year. These guys are just delaying to shut down the business.

stockprofitter

stockprofitter 13 minuti fa

News of Trump release is HOT 💥🔥

ksquared

ksquared 13 minuti fa

Here you go, Larry... Kentucky Science Center apologizes for distribution of 'Adult' coloring book to kids at recent event
The downtown Louisville organization blamed Planned Parenthood, which vehemently denied the book was distributed at all.
Mar 26, 2025 Updated 2 hrs ago

jmgotch

jmgotch 14 minuti fa

10 cents. Equals. 2 weeks notice. Go mcic.

Polymer Paul

Polymer Paul 14 minuti fa

Did the shorts force lebby out ? Lmao ... Just admit it .. you can't come to terms with it that you have been scammed! Don't worry... It will kick in soon enough... You can join Carlin .. heard he lost everything and is now in a mental ward.. to be fair that's where most of you belong! Nutters

jimmybob

jimmybob 15 minuti fa

lovethatgreen

lovethatgreen 15 minuti fa

It states CSE not TSX in their statement.
CSE has slacker rules for listing than the TSX so I really don't know how the minimum bid price is even going to be an issue. Not sure why they even bother with the CSE

Ranb2khz

Ranb2khz 16 minuti fa

Russian Ransomware Gang Exploited Windows Zero-Day Before Patch

~ Exploitation of Windows MMC zero-day is being pinned on a ransomware gang known as EncryptHub (an affiliate of RansomHub).

~ by Ryan Naraine March 26, 2025

Security researchers at Trend Mic

jbog

jbog 16 minuti fa

Regulus' farabursen shows efficacy in Phase 1b kidney disease trial

Regulus announced positive topline results from all patients in the fourth cohort in its Phase 1b MAD study of farabursen for the treatment of autosomal dominant polycystic kidney disease, or ADPKD. The Phase 1b MAD

Capital One Financial

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni